Latest News
-
Jan. 24. 2025Event
-
Oct. 31. 2024News Release
TEIJIN CDMO's strength


One-stop solution for manufacturing of cell based products


Accomplishments of 5 regulatory approvals in regenerative medicine
※As of April 2024

Supports of vector manufacturing and overseas clinical trials
Questionnaire
about your needs
Please share your needs for process development, manufacturing,
analysis in cell & gene therapies/regenerative medicines.
(About 5 min)